Survival of adult patients with cancer of soft tissues or bone in Europe
Survival of adult patients with cancer of soft tissues or bone in Europe
复制标题
DOI：
10.1016/s0959-8049(98)00335-9
复制
发表时间：
1998-12-01
影响因子：
8.4
通讯作者：
Storm, HH
中科院分区：
文献类型：
--
作者：
Storm, HH
使用EUROCARE II数据库的数据，分别研究了欧洲软组织肉瘤（STS）和骨癌成人患者的相对生存率。共纳入2，151例骨癌和5，845例STS。对每种性别进行生存分析，并计算观察到的生存期与预期生存期之间的比值。骨癌的1年相对生存率男性为65%，女性为71%，5年相对生存率男性为45%，女性为51%。对于STS，男性1年相对生存率为78%，女性为79%，男性和女性的5年相对生存率均为59%。各国之间骨癌的相对存活率差异很大，东部国家的比率最低。在北欧国家中，丹麦的发病率最低，与苏格兰相似。STS的存活率差异不太明显，但东欧国家的存活率仍然较低。本分析在欧洲STS亚组中进行，不包括内脏STS。为了充分评估生存率的国际差异，必须根据报告的肉瘤形态对STS进行回顾。(C)1998爱思唯尔科技有限公司版权所有。
Using data from the EUROCARE II database, relative survival rates for Europe were studied for adult patients with soft tissue sarcomas (STS) and bone cancers separately. Altogether 2,151 bone cancers and 5,845 STS were included. Survival analysis was carried out for each gender and the ratio between observed and expected survival calculated. One-year relative survival for bone cancer was 65% in men and 71% in women, and 5-year relative survival 45% in men and 51% in women. For STS 1-year relative survival was 78% for men and 79% for women and 5-year relative survival was 59% for both sexes. The variation in relative survival for bone cancer between countries was substantial, with the lowest rates seen in the Eastern countries. Denmark had the lowest rates of the Nordic countries, similar to those of Scotland. The variation in survival rates for STS was less pronounced, but still rates tended to be lower in Eastern European countries. The present analysis was carried out in the subset of European STS excluding visceral STS. To assess fully the international variation in survival a review of STS based on reported sarcoma morphology must be carried out. (C) 1998 Elsevier Science Ltd. All rights reserved.